Clinical Trial Update: DDR Genes Alteration and Response to Platinum-based Chemotherapy in Advanced Urothelial Cancer. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating how DDR gene alterations influence response to platinum-based chemotherapy in advanced urothelial cancers. The study recruits …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Upper Tract Urothelial Carcinoma

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable, Upper Tract Urothelial Cancer | Phase 4 | Status: RECRUITING